Why the FDA Must Lift Unnecessary Restrictions on Medication Abortion Care Now
The Democratic congresswomen of the House Oversight Committee are putting pressure on the Food and Drug Administration to lift the in-person dispensing requirement for mifepristone—a prescription medication that’s used to safely end early pregnancies in the United States. During the coronavirus pandemic, safe access to medication abortion is more important than ever, but being required to obtain the medication in person places a burden on individuals. Below, Committee Chairwoman Carolyn Maloney and Committee Member Ayanna Pressley explain how onerous these restrictions really are and urge the FDA to lift them...